Latest papers

Treatment for lupus, first in 50 years, offers modest benefits, hope to patients.

Commentary on neuropsychiatric symptoms associated with lupus.

Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus.

Case records of the Massachusetts General Hospital. Case 11-2011. A 47-year-old man with systemic lupus erythematosus and heart failure.

Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.

Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus.

A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients.

Proteome analysis of biological fluids from autoimmune-rheumatological disorders.

Lack of association between RANTES-28, SDF-1 gene polymorphisms and systemic lupus erythematosus in the Malaysian population.

[Benlysta. Finally, the first medication for lupus].

Molecular basis of applied biological therapeutics.

Isoniazid (INH)-induced eosinophilic exudative pleural effusion and lupus erythematosus. A clinical reminder of drug side effects.

IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions.

Ending the 50-year drought of FDA drug approval for SLE.

Transglutaminase 2 dysfunctions in the development of autoimmune disorders: celiac disease and TG2-/- mouse.

Interleukin 6 inhibition - RA and beyond.

[Late results of high-dose immunosuppressive therapy with autotransplantation of hematopoietic stem cells in patients with severe refractory systemic lupus erythematosus].

Abnormalities of B cell subsets in patients with systemic lupus erythematosus.

[Mitral valve replacement for mitral valve stenosis and insufficiency in a patient with antiphospholipid syndrome and systemic lupus erythematosus; report of a case].

Oral manifestations of systemic disease.